| Multiple basic
technologies (called platforms) are being developed to capture microbes
for detection. The aim of all platforms is single cell detection in less
than 15 minutes.
Current platforms
-
Immunoflow
-(patent 5,998,222)
a. large scale
b. bench scale
-
Immuno
DNA-(patent pending)This platform currently detects 1 cell in 30-60
minutes. This technology uniquely combines DNA and antibodies to minimize
background in a thermally-controlled environment.
-
GlycoBind-(patent
pending)A microbe receptor-based sensor capable of single cell detection
of microbes as well as toxin. It is more stable environmentally and offers
more flexability than previous platforms.
-
TissueTag
-
Receptor DNA
-
Automation
Automation is currently
being developed in collaboration with a commercial partner.
See comparison
chart.
|
Large Scale Immunoflow
Sensor
Bench Scale Immunoflow
Sensor
|